3.8 Article

Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study

Journal

EUROPEAN JOURNAL OF HOSPITAL PHARMACY
Volume 29, Issue E1, Pages E15-E22

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/ejhpharm-2020-002574

Keywords

drug-related side effects and adverse reactions; microbiology; clinical medicine; controlled clinical trial; education department; hospital; gastrointestinal neoplasms; head and neck neoplasms; hematology; kidney neoplasms; leukemia; multiple myeloma; transplantation; urologic neoplasms

Funding

  1. Ministry of Defence of the Republic of Serbia [MF VMA 05/20-22]

Ask authors/readers for more resources

This study investigated differences in outcomes associated with healthcare-associated Clostridioides difficile infection in patients with solid and haematological malignancies compared to patients with no underlying malignant disease. The results showed that patients with haematological malignancy faced different risk factors for CDI-associated mortality compared to patients with solid tumours and non-cancer patients. Older age, ICU stay, and mechanical ventilation, rather than the presence or type of cancer, were predictors of all-cause 30-day mortality.
Background Clostridioides difficile infection (CDI) is one of the most common healthcare-associated (HA) infections. Cancer patients, particularly haemato-oncological patients, have an increased risk for CDI due to more risk factors compared with non-cancer patients. The aim of this study was to investigate differences in outcomes associated with HA CDI in patients with solid and haematological malignancies compared with patients with no underlying malignant disease in a tertiary healthcare centre in Serbia. Methods A prospective cohort study was conducted including adult patients diagnosed with an initial episode of HA CDI. Their demographic and clinical characteristics associated with risk factors for CDI were documented. Outcomes such as all-cause 30-day mortality, cure of infection, diarrhoea relaps and recurrence of disease were followed. Patients were assigned to cancer and non-cancer groups. Within the cancer group, patients were divided into the solid tumour subgroup and haematological malignancy subgroup. Results During a 7-year period, HA CDI was observed in 28 (5.1%) patients with haematological malignancy, 101 (18.3%) patients with solid tumours and 424 (76.7%) non-cancer patients. Older age (OR 1.04, 95% CI 1.02 to 1.07, p<0.001), admission to the intensive care unit (ICU) (OR 2.61, 95% CI 1.37 to 4.95, p=0.003), mechanical ventilation (OR 5.19, 95% CI 2.78 to 9.71, p<0.001) and use of antibiotics prior to CDI (OR 1.04, 95% CI 1.02 to 1.06, p=0.02) were associated with increased mortality. Compared with patients with solid tumours, patients with haematological malignancy were younger (65 vs 57 years, p=0.015), did not require ICU admission (25.0% vs 0%) or mechanical ventilation (8.9% vs 0%) and were treated longer with antibiotics prior to CDI (14 vs 24 days, p=0.002). Conclusions Patients with haematological malignancy were exposed to different risk factors for CDI associated with mortality compared with patients with solid tumours and non-cancer patients. Older age, ICU stay and mechanical ventilation, but not presence or type of cancer, predicted the all-cause 30-day mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available